During childhood, a protein called DENND2B plays a big role in spurring the migration of cells, a condition that fades as well. But now a team at the Montreal Neurological Institute says that they have discovered that the protein also appears to play a part in promoting metastasis.
Researchers at The University of Texas MD Anderson Cancer Center say they've devised a new strategy for attacking breast cancer tumors before they metastasize.
Investigators at the University of California-San Diego say they've identified a crucial link between obesity and diabetes, and now they're zeroing in on a new drug that can break it.
A research team at the National University of Singapore has published a paper on a novel strategy to prevent progression of inflammation-associated cancers.
SINGAPORE-- Nanyang Technological University (NTU) researchers in Singapore working with colleagues at other local institutions have developed an antibody with the potential to help patients suffering from pneumonia and influenza to recover faster, NTU said in a news release.
Antibiotic R&D fell out of favor at Big Pharma companies years ago, chilling a field that only recently has shown signs of heating up with new development projects. But a transatlantic team of investigators electrified the field this week with its claims that a new antibiotic found in dirt was a potent killer of drug-resistant bacteria. And it could represent a new class of badly needed antibiotics that just might avoid the natural resistance that begins to evolve once a new antibiotic hits the market.
In an effort to better understand a certain disease-causing enzyme, British researchers have created a "map" of more than 100 proteins this enzyme is known to affect. They then identified a druglike molecule that blocks this enzyme to preserve these essential proteins.
Scientists at the New York University Langone Medical Center have developed a new technique that uses three familiar compounds, including vitamin C, to generate adult stem cells into pluripotent stem cells at a dramatically more efficient rate--more than 20-fold compared to the current method.
A new strategy that uses broadly neutralizing antibodies combined with a cocktail of viral-inducing compounds may be able to stop HIV from rebounding, according to researchers at Rockefeller University.
A bacteria-based injectable therapy shrunk tumors and completely eradicated others when tested in dogs and rats, according to a new study.